Association between allostatic load and breast cancer risk: a cohort study

IF 6.1 1区 医学 Q1 ONCOLOGY
Yufan Guan, Jie Shen, Juan Lu, Bernard F. Fuemmeler, Lisa S. Shock, Hua Zhao
{"title":"Association between allostatic load and breast cancer risk: a cohort study","authors":"Yufan Guan, Jie Shen, Juan Lu, Bernard F. Fuemmeler, Lisa S. Shock, Hua Zhao","doi":"10.1186/s13058-023-01754-w","DOIUrl":null,"url":null,"abstract":"Allostatic load (AL) reflects the collective load of chronic stress during lifetime. Previous studies have shown that higher AL is associated with poor clinical outcomes among breast cancer patients. However, the relationship between AL and breast cancer risk is still unclear. To fill the gap, we analyzed the association between AL and the development of breast cancer in 181,455 women identified from the UK Biobank. During the follow-up from 2006 to 2020, 5,701 women were diagnosed with incident breast cancer. Significantly higher AL was observed among incident breast cancer cases than all study participants (mean: 2.77 vs. 2.63, P < 0.01). Univariate Cox regression analysis indicated the risk of breast cancer was increased by 5% per one AL unit increase (hazard ratio (HR) = 1.05, 95% confidence interval (CI) 1.04, 1.07). In multivariate analyses, after adjusting demographics, family history of breast cancer, reproductive factors, socioeconomic status, lifestyle factors, and breast cancer polygenic risk score (PRS), the significant association remained (HR = 1.05, 95%CI 1.03, 1.07). The significant relationship was further confirmed in the categorical analysis. Compared with women in the low AL group (AL: 0 ~ 2), those in the high AL group (AL: 3 ~ 11) had a 1.17-fold increased risk of breast cancer (HR = 1.17, 95%CI 1.11, 1.24). Finally, in the stratified analysis, joint effects on the risk of breast cancer were observed between the AL and selected known breast cancer risk factors, including age, family history of breast cancer, PRS, income, physical activity, and alcohol consumption. In summary, those findings have demonstrated that higher AL was associated with an increased breast cancer risk in women. This association is likely independent of known breast cancer risk factors. Thus, the AL could be a valuable biomarker to help breast cancer risk prediction and stratification.","PeriodicalId":9222,"journal":{"name":"Breast Cancer Research","volume":"36 1","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13058-023-01754-w","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Allostatic load (AL) reflects the collective load of chronic stress during lifetime. Previous studies have shown that higher AL is associated with poor clinical outcomes among breast cancer patients. However, the relationship between AL and breast cancer risk is still unclear. To fill the gap, we analyzed the association between AL and the development of breast cancer in 181,455 women identified from the UK Biobank. During the follow-up from 2006 to 2020, 5,701 women were diagnosed with incident breast cancer. Significantly higher AL was observed among incident breast cancer cases than all study participants (mean: 2.77 vs. 2.63, P < 0.01). Univariate Cox regression analysis indicated the risk of breast cancer was increased by 5% per one AL unit increase (hazard ratio (HR) = 1.05, 95% confidence interval (CI) 1.04, 1.07). In multivariate analyses, after adjusting demographics, family history of breast cancer, reproductive factors, socioeconomic status, lifestyle factors, and breast cancer polygenic risk score (PRS), the significant association remained (HR = 1.05, 95%CI 1.03, 1.07). The significant relationship was further confirmed in the categorical analysis. Compared with women in the low AL group (AL: 0 ~ 2), those in the high AL group (AL: 3 ~ 11) had a 1.17-fold increased risk of breast cancer (HR = 1.17, 95%CI 1.11, 1.24). Finally, in the stratified analysis, joint effects on the risk of breast cancer were observed between the AL and selected known breast cancer risk factors, including age, family history of breast cancer, PRS, income, physical activity, and alcohol consumption. In summary, those findings have demonstrated that higher AL was associated with an increased breast cancer risk in women. This association is likely independent of known breast cancer risk factors. Thus, the AL could be a valuable biomarker to help breast cancer risk prediction and stratification.
代谢负荷与乳腺癌风险之间的关系:一项队列研究
静态负荷(AL)反映了人一生中慢性压力的集体负荷。以往的研究表明,AL 越高,乳腺癌患者的临床预后越差。然而,AL 与乳腺癌风险之间的关系仍不清楚。为了填补这一空白,我们分析了英国生物库中 181,455 名女性的 AL 与乳腺癌发病之间的关系。在 2006 年至 2020 年的随访期间,有 5701 名女性被诊断为乳腺癌。观察发现,乳腺癌病例中的AL值明显高于所有研究参与者(平均值:2.77 vs. 2.63,P < 0.01)。单变量 Cox 回归分析表明,AL 每增加一个单位,患乳腺癌的风险就会增加 5%(危险比 (HR) = 1.05,95% 置信区间 (CI) 1.04,1.07)。在多变量分析中,对人口统计学、乳腺癌家族史、生殖因素、社会经济地位、生活方式因素和乳腺癌多基因风险评分(PRS)进行调整后,仍存在显著关联(HR = 1.05,95%CI 1.03,1.07)。分类分析进一步证实了这一重要关系。与低 AL 组(AL:0 ~ 2)的妇女相比,高 AL 组(AL:3 ~ 11)的妇女罹患乳腺癌的风险增加了 1.17 倍(HR = 1.17,95%CI 1.11,1.24)。最后,在分层分析中,观察到 AL 与某些已知乳腺癌风险因素(包括年龄、乳腺癌家族史、PRS、收入、体力活动和饮酒量)之间对乳腺癌风险的共同影响。总之,这些研究结果表明,AL 值越高,女性患乳腺癌的风险越高。这种关联可能与已知的乳腺癌风险因素无关。因此,AL 可以作为一种有价值的生物标志物,帮助预测和分层乳腺癌风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Breast Cancer Research
Breast Cancer Research 医学-肿瘤学
自引率
0.00%
发文量
76
期刊介绍: Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信